Sunshine Biopharma Management

How experienced are the management team and are they aligned to shareholders interests?

13.0yrs

Average management tenure


CEO

Steve Slilaty (70 yo)

13yrs

Tenure

US$462,380

Compensation

Dr. Steve N. Slilaty, Ph D., serves as the President, Chief Executive Officer and Chief Scientific Officer of Advanomics Corporation since February 2002. Dr. Slilaty serves as the Chairman, Chief Executive...


CEO Compensation Analysis

Steve Slilaty's Compensation vs Sunshine Biopharma Earnings
How has Steve Slilaty's remuneration changed compared to Sunshine Biopharma's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$462kUS$156k

-US$12m

Sep 30 2021n/an/a

-US$14m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$227kUS$177k

-US$3m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$972k

Dec 31 2019US$96kUS$28k

-US$1m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$285kUS$85k

-US$2m

Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$1m

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$268kUS$156k

-US$1m

Sep 30 2017n/an/a

-US$2m

Jun 30 2017n/an/a

-US$3m

Mar 31 2017n/an/a

-US$3m

Dec 31 2016US$166kUS$1k

-US$3m

Sep 30 2016n/an/a

-US$3m

Jun 30 2016n/an/a

-US$2m

Mar 31 2016n/an/a

-US$2m

Dec 31 2015US$50kn/a

-US$2m

Compensation vs Market: Steve's total compensation ($USD462.38K) is below average for companies of similar size in the US market ($USD772.75K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SBFM's management team is seasoned and experienced (13 years average tenure).


Board Members

Experienced Board: SBFM's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.